Coherus Oncology Inc (CHRS)

Working Capital Ratio

30.48%

Quarterly · Period ending:

CHRS logo

CHRS Working Capital Ratio

Latest reported25.09%
CHRS FY Working Capital Ratio (51.05% → 25.09%)
High-resolution chart · PNG

CHRS working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
25.0945%
13.0653%
22.8493%
50.4402%
64.3271%
73.8819%
55.7655%
39.3045%
60.5838%
38.4184%
24.5819%
52.6698%
-16.9115%
51.0534%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.